Publication Ethics and Publication Malpractice Statement
The Journal of Medical Pharmaceutical and Allied Sciences (JMPAS) follows the COPE Code of Conduct and Best Practice Guidelines for Journal Editors and the Code of Conduct for Journal Publishers, as well as the ICMJE's Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
Authors:
Authorship and Contributorship: Authorship should be limited to those who have significantly contributed to the conception, design, execution, or interpretation of the study. All significant contributors must be listed as co-authors, while others who participated in certain aspects should be acknowledged. The corresponding author is responsible for ensuring the inclusion of appropriate co-authors and their approval of the final manuscript.
Complaints and appeals handling: The Journal of Medical Pharmaceutical and Allied Sciences follows the COPE guidelines in dealing with cases of potential publication misconduct.
Complaints of publication misconduct can be sent to the editor-in-chief of the journal directly or to the editorial office by email or by completing a feedback form, as provided in the journal's "Contact us" page ( https://jmpas.com/contact-us). Please clearly identify yourself when contacting us.
The Editors-in-chief, and/or editorial office take ethical concerns, complaints, and accusations of research misconduct extremely seriously and conduct investigations. For purposes of research and confirmation, the editors and editorial office reserve the right to get in touch with the authors, colleges, and other institutions. According to COPE guidelines, actions may be taken which include rejection, withdrawal, issuing a correction or expression of concern, or retracting the article, depending on the extent of the misconduct following investigation.
Policies on conflicts of interest: A conflict of interest arises when a participant in the publication process, such as authors, reviewers, editors, or journal staff, has financial, personal, or professional relationships that may influence their actions, decisions, or judgments related to the submission, peer review, or publication of a manuscript. Details are provided at https://jmpas.com/policies-of-conflict-of-interest.
Journal policies on data sharing and reproducibility: At the Journal of Medical and Pharmaceutical Allied Sciences (JMPAS), we recognize the importance of data sharing in promoting scientific transparency, reproducibility, and collaboration. Our data-sharing policy aims to facilitate the responsible and ethical sharing of research data. Details are provided at https://jmpas.com/data-sharing-policy
Policy on ethical oversight: The policy is based on the expectation that all publication ethics principles will be followed, and that participants in the publication process have mutual trust. The policy follows the principles of best practice and transparency for scientific publications. These principles are from the Committee on Publication Ethics https://publicationethics.org/oversight.
Journal’s policy on intellectual property: The journal follows the Committee on Publication Ethics (COPE) guideline https://publicationethics.org/intellectualproperty
Journal’s options for post-publication discussions and corrections: The journal follows the Committee on Publication Ethics (COPE) guideline https://publicationethics.org/postpublication.
Plagiarism and Originality: Authors must ensure that their work is original and properly cited. Plagiarism, including the use of previously published text or data without proper attribution, is strictly prohibited.
Copyright and Multiple Publication: Authors must sign a copyright form affirming that the manuscript is original and has not been published elsewhere. Simultaneous submission to other journals is not allowed.
Reporting Standards: Authors should present an accurate account of their work and provide sufficient detail and references to enable replication. Fraudulent or knowingly inaccurate statements are unacceptable.
Data Access and Retention: Authors may be required to provide raw data for review and should retain data for a reasonable time after publication.
Reviewers:
Contribution to Editorial Decisions: Reviewers play a vital role in editorial decisions and should provide constructive feedback to authors.
Confidentiality: Reviewers must treat manuscripts as confidential and refrain from discussing them with unauthorized individuals.
Objectivity: Reviews should be conducted objectively, avoiding personal criticism of the authors.
Acknowledgment of Sources: Reviewers should identify relevant published work that authors may have missed.
Conflict of Interest: Reviewers should recuse themselves from evaluating manuscripts in which they have conflicts of interest.
Editors:
Publication Decisions: Editors are responsible for deciding which manuscripts are published based on their importance, originality, and relevance to the journal's aim.
Fair Play: Manuscripts should be evaluated without bias based on authors' race, gender, religion, etc.
Confidentiality: Editors and editorial staff must maintain the confidentiality of submitted manuscripts.
Disclosure and Conflict of Interest: Editors should recuse themselves from handling manuscripts with conflicts of interest and ensure that authors disclose relevant competing interests.
Unethical Behavior: Editors should address unethical behavior seriously and take appropriate actions when misconduct is suspected or reported.
Digital Archiving: Editors should ensure the digital preservation of journal content with appropriate archiving institutions.
Reviewer's Responsibilities: Editors should ensure that reviewers fulfill their duties in a timely and objective manner.
The journal encourages authors to adhere to ethical standards, avoid plagiarism, provide accurate and original data, and follow guidelines on authorship and publication. Reviewers are expected to provide fair and constructive evaluations, while editors uphold transparency and make informed editorial decisions. Any unethical behavior reported will be thoroughly investigated, and appropriate measures will be taken to maintain the integrity and quality of publications in the Journal of Medical Pharmaceutical and Allied Sciences.